Researchers Outline Agenda to Elucidate Caregivers’ Experience

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 9
Volume 10
Issue 9

EAST LANSING, Mich-Although much of cancer care now takes place in the outpatient and home setting, the oncology care system has not fully incorporated "family care" for patients at home. While this shift has translated into increased family involvement in day-to-day care, there are few documented, effective strategies to guide family members caring for patients with advanced cancer.

EAST LANSING, Mich—Although much of cancer care now takes place in the outpatient and home setting, the oncology care system has not fully incorporated "family care" for patients at home. While this shift has translated into increased family involvement in day-to-day care, there are few documented, effective strategies to guide family members caring for patients with advanced cancer.

The cover article of the July/August 2001 issue of CA—A Cancer Journal for Clinicians calls for a research agenda to more fully elucidate the cancer caregiver’s experience throughout the illness and treatment trajectory, and identify the means to effecting positive outcomes for people with cancer, their family caregiver, and the health care system.

"Caregivers’ well being must be our concern," say authors Barbara Given, RN, PhD; Charles Given, PhD; and Sharon Kozachik, RN, MSN, of Michigan State University. They suggest four areas for future research: symptom management strategies, patient-caregiver communication, defining patient outcomes, and cost effectiveness. 

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content